Clinical trial
A Randomized, Placebo-Controlled Parallel-Design Trial of the Effect of Solifenacin Treatment for Overactive Bladder in Women With Anterior Vaginal Wall Prolapse Managed With a Pessary (the "PESSARY" Study)
NCT01092624 is registered in ClinicalTrials.gov with Hartford Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Placebo-Controlled Parallel-Design Trial of the Effect of Solifenacin Treatment for Overactive Bladder in Women With Anterior Vaginal Wall Prolapse Managed With a Pessary (the "PESSARY" Study)
- Lead sponsor
- Hartford Hospital
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- March 31, 2010
- Completion date
- October 31, 2011
- Enrollment
- 94 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.